Endovascular Today

Artivion’s AMDS Hybrid Prosthesis Approved by FDA

Artivion, Inc. announced that the FDA has approved the company’s AMDS hybrid prosthesis, an aortic arch remodeling device fo ...
Zacks Investment Research on MSN

Artivion secures FDA approval for AMDS hybrid prosthesis device

Artivion AORT recently secured FDA premarket approval (“PMA”) for its AMDS Hybrid Prosthesis to treat acute DeBakey Type I ...

Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion

Artivion benefits from FDA premarket approval of AMDS, removing adoption barriers and unlocking a $150M U.S. TAM in acute ...
Pharmabiz

US FDA grants premarket approval for Artivion’s AMDS Hybrid Prosthesis

US FDA grants premarket approval for Artivion’s AMDS Hybrid Prosthesis: Atlanta Artivion, Inc., a leading cardiac and vascular surgery c ...
Nasdaq

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Full IDE Data Set Demonstrates Sustained Benefit at One Year with Use of AMDS in Acute DeBakey Type I (ADTI) Dissections Complicated by Malperfusion Data from the trial demonstrate sustained benefit ...

Artivion, Inc.: Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that ...
EurekAlert!

Management and outcomes of aortic dissection in pregnancy with Marfan Syndrome

Hemodynamic adaptations taking place during pregnancy increases the risk of cardiovascular complications including acute aortic dissection (AoD) and may lead to increased maternal and foetal morbidity ...